Supplementary Table 4. Proportional hazards.
| Study | Population | Outcome | Treat. Effects HR | PH schoenfeld residuals test p-value | RMST difference |
|---|---|---|---|---|---|
| RUBY | DMMR | OS | 0.34 (0.18–0.66) |
0.2102 | |
| RUBY | PMMR | OS | 0.78 (0.59–1.03) |
0.8534 | |
| RUBY | DMMR | PFS | 0.33 (0.19–0.56) |
0.0240 | 10.618 (6.194–15.043) |
| RUBY | PMMR | PFS | 0.76 (0.59–0.98) |
0.7479 | |
| NGR | DMMR | PFS | 0.30 (0.19–0.48) |
0.6850 | |
| NGR | PMMR | PFS | 0.56 (0.43–0.73) |
0.3477 | |
| NGR | DMMR | OS | 0.58 (0.26–1.29) |
0.7602 | |
| NGR | PMMR | OS | 0.78 (0.53–1.15) |
0.4321 | |
| MITO | PMMR | PFS | 1.18 (0.67–2.07) |
0.5684 | |
| MITO | DMMR | PFS | 0.39 (0.19–0.78) |
0.6772 | |
| MITO | PMMR | OS | 0.54 (0.23–1.29) |
0.0412 | 4.549 (−2.564–11.662) |
| MITO | DMMR | OS | 0.36 (0.13–1.02) |
0.5480 | |
| DUOE | DMMR | PFS | 0.43 (0.22–0.82) |
0.8668 | |
| DUOE | PMMR | PFS | 0.79 (0.62–1.00) |
0.0173 | 2.097 (0.279–3.916) |
| DUOE | DMMR | OS | 0.34 (0.14–0.81) |
0.7513 | |
| DUOE | PMMR | OS | 0.92 (0.64–1.31) |
0.7995 | |
| ATTEND | DMMR | PFS | 0.37 (0.23–0.59) |
0.4594 | |
| ATTEND | PMMR | PFS | 0.92 (0.73–1.16) |
0.1418 | |
| ATTEND | DMMR | OS | 0.41 (0.21–0.79) |
0.4010 | |
| ATTEND | PMMR | OS | 1.00 (0.74–1.35) |
0.1127 |
Bold values: p < 0.05